Dr. Marzenna Wiranowska

University of South Florida, USA

Email: [email protected]

Qualifications

1980 Ph.D., Polish Academy of Sciences, Virology-Immunology

1974 M.Sc., Medical Academy of Warsaw, Microbiology-Immunology

1972 B.Sc., Warsaw University, Biology

Publications (Selected)

1. Wiranowska, M. (2024). Advances in the use of chitosan and chlorotoxin-functionalized chitosan polymers in drug delivery and detection of glioma–A review. Carbohydrate Polymer Technologies and Applications, 7, 100427.
2. Wiranowska, M., Singh, R., Falahat, R., Williams, E., Johnson, J. O., & Alcantar, N. (2020). Preferential drug delivery to tumor cells than normal cells using a tunable niosome–chitosan double package nanodelivery system: a novel in vitro model. Cancer Nanotechnology, 11(1), 3.
3. Wiranowska, M., Toomey, R., Falahat, R., & Alcantar, N. (2019). Design for a flexible localized drug delivery system. Cancer Research, 79(13_Supplement), 3615-3615.
4. Roberts, A. D., Johnson, J. O., Karolak, A., Alcantar, N., Rejniak, K. A., & Wiranowska, M. (2018). Quantitative assessment of the intracellular uptake of chlorotoxin in a U87 human glioma mouse model for the targeted drug delivery system. Cancer Research, 78(13_Supplement), 4650-4650.
5. Singh, R., Falahat, R., Williams, E., Johnson, J. O., Alcantar, N., Karolak, A., ... & Wiranowska, M. (2017, July). Cross-disciplinary optimization of nano-drug delivery to ovarian carcinoma and glioma cells. In Cancer Research (Vol. 77). 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA: AMER ASSOC CANCER RESEARCH.
6. Falahat, R., Wiranowska, M., Toomey, R., & Alcantar, N. (2016). ATR-FTIR analysis of spectral and biochemical changes in glioma cells induced by chlorotoxin. Vibrational Spectroscopy, 87, 164-172.
7. Falahat, R., Wiranowska, M., Toomey, R., & Alcantar, N. (2016). Interactions of glioma cells with chlorotoxin: an ATR-FTIR spectroscopy study. Cancer Research, 76(14_Supplement), 3909-3909.
8. Falahat, R., Wiranowska, M., Gallant, N. D., Toomey, R., Hill, R., & Alcantar, N. (2015). A Cell ELISA for the quantification of MUC1 mucin (CD227) expressed by cancer cells of epithelial and neuroectodermal origin. Cellular Immunology, 298(1-2), 96-103.
9. Falahat, R., Williams, E., Wiranowska, M., Toomey, R., & Alcantar, N. (2015). Enhanced targeted delivery of paclitaxel to tumor cells of epithelial and neuroectodermal origin using chlorotoxin-chitosan nanodelivery system. Cancer Research, 75(15_Supplement), 3677-3677.
10. Wiranowska, M., Rojiani, A. M., & Rojiani, M. V. (2015). Matrix Metalloproteinases-Modulating the Tumor Microenvironment. J Carcinog Mutagen.[Internet]. OMICS International.
11. Falahat, R., Williams, E., Wiranowska, M., Toomey, R., & Alcantar, N. (2014). Enhanced targeting delivery to tumor cells using mucoadhesive chitosan and chlorotoxin. Cancer Research, 74(19_Supplement), 5410-5410.
12. Falahat, R., Williams, E. C., Wiranowska, M., Toomey, R., & Alcantar, N. (2013). Targeted delivery to tumor cells by using tunable nano-delivery system with chlorotoxin. Cancer Research, 73(8_Supplement), 4523-4523.
13. Williams, E. C., Alcantar, N., & Wiranowska, M. (2013). Nano-particle based delivery of therapeutics to glioma. In Gliomas: symptoms, diagnosis and treatment options. New York: Nova Science Publishers Inc.
14. Williams, E. C., Wiranowska, M., Gordon, M., Toomey, R., Nicolas, G., & Alcantar, N. (2012). Preferential drug delivery to cancer cells than to normal cells by using the Niosome-Chitosan Thermo-responsive Double Package System (NCTR-DPS). Cancer Research, 72(8_Supplement), 2897-2897.
15. Wiranowska, M., & Rojiani, M. V. (2011). Extracellular matrix microenvironment in glioma progression. Glioma—Exploring Its Biology and Practical Relevance, 257.
16. Wiranowska, M., Colina, L. O., & Johnson, J. O. (2011). Clathrin-mediated entry and cellular localization of chlorotoxin in human glioma. Cancer cell international, 11(1), 27.
17. Williams, E. C., Wiranowska, M., Toomey, R., & Alcantar, N. (2011). Thermo-responsive double packaged system for localized drug delivery for cancer treatment. Cancer Research, 71(8_Supplement), 3229-3229.
18. Falahat, R., Williams, E., Wiranowska, M., Toomey, R., & Alcantar, N. (2014). Enhanced targeting delivery to tumor cells using mucoadhesive chitosan and chlorotoxin. Cancer Research, 74(19_Supplement), 5410-5410.
19. Falahat, R., Williams, E. C., Wiranowska, M., Toomey, R., & Alcantar, N. (2013). Targeted delivery to tumor cells by using tunable nano-delivery system with chlorotoxin. Cancer Research, 73(8_Supplement), 4523-4523.
20. Williams, E. C., Alcantar, N., & Wiranowska, M. (2013). Nano-particle based delivery of therapeutics to glioma. In Gliomas: symptoms, diagnosis and treatment options. New York: Nova Science Publishers Inc.
21. Wiranowska, M., & Rojiani, M. V. (2013). Glioma extracellular matrix molecules as therapeutic targets. In Gliomas: Symptoms, Diagnosis and Treatment Options (pp. 263-285). Nova Science Publishers, Inc..
22. Williams, E. C., Wiranowska, M., Gordon, M., Toomey, R., Nicolas, G., & Alcantar, N. (2012). Preferential drug delivery to cancer cells than to normal cells by using the Niosome-Chitosan Thermo-responsive Double Package System (NCTR-DPS). Cancer Research, 72(8_Supplement), 2897-2897.
23. Wiranowska, M., & Rojiani, M. V. (2011). Extracellular matrix microenvironment in glioma progression. Glioma—Exploring Its Biology and Practical Relevance, 257.
24. Wiranowska, M., Colina, L. O., & Johnson, J. O. (2011). Clathrin-mediated entry and cellular localization of chlorotoxin in human glioma. Cancer cell international, 11(1), 27.
25. Williams, E. C., Wiranowska, M., Toomey, R., & Alcantar, N. (2011). Thermo-responsive double packaged system for localized drug delivery for cancer treatment. Cancer Research, 71(8_Supplement), 3229-3229.

Profile Details

https://www.researchgate.net/scientific-contributions/Marzenna-Wiranowska-39734074

https://hscweb3.hsc.usf.edu/blog/2022/09/21/mcom-celebrates-newest-distinguished-educators/

https://www.linkedin.com/in/marzenna-wiranowska-582b1028/